Completed OBSERVATIONAL NCT06830525
Development of a Personalized Growth Hormone Treatment Profile (PGTP) Report for Pediatric Endocrinology (PGTP)
Sponsor: Hospital Miguel Servet
Conditions
Growth Hormone Deficiency (GHD)
Interventions
ACDP® and growth hormone treatment
Updated 3 times since 2025 Last updated: Nov 27, 2025 Started: May 19, 2025 Primary completion: Nov 12, 2025 Completion: Nov 12, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06830525, this observational or N/A phase trial focuses on Growth Hormone Deficiency (GHD) and remains completed. Sponsored by Hospital Miguel Servet, it has been updated 3 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
3 versions recorded-
Jan 2026 — Present [monthly]
Completed
Status: Recruiting → Completed
-
Jun 2025 — Jan 2026 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Mar 2025 — Jun 2025 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Hospital Miguel Servet
- Luis Fernandez Luque
Data source: Adhera Health, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .